% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bhave:307313,
author = {R. Bhave$^*$ and C.-J. Kath$^*$ and N. Rüchel$^*$ and E.
Vasileiou and V. H. Jepsen$^*$ and K. Raba and A. A. Pandyra
and U. Fischer$^*$ and G. Kogler},
title = {{S}erum-free differentiation platform for the generation of
{B} lymphocytes and natural killer cells from human {CD}34+
cord blood progenitors.},
journal = {Scientific reports},
volume = {15},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Springer Nature},
reportid = {DKFZ-2025-02999},
pages = {44132},
year = {2025},
abstract = {Pre-clinical research on B and NK cell development relies
on murine stromal cell-based systems with reduced
physiological relevance and clinical applicability. A
serum-free, fully humanized co-culture system utilizing
human bone marrow-derived mesenchymal stromal cells
(BM-MSCs) was developed to differentiate CB-CD34+ cells
towards B and NK cell lineages. Differentiation dynamics
were monitored via flow cytometry, with immunophenotypic
analysis tracking progression from progenitors to mature
cells. The system generated CD19+ IgM+ immature B cells and
CD56+ CD16+ NK cells, recapitulating fetal stages of human
lymphopoiesis. Serum-free media conditions ensured
reproducibility and high overall yield of CD19+ B (35 ±
$5.32\%)$ and CD56+ NK (28.46 ± $7.01\%)$ cell progenitors.
Flow cytometry identified distinct population peaks,
confirming temporal control over differentiation. This
clinically relevant platform addresses the limitations of
traditional models by providing a more physiologically
accurate human microenvironment. The serum-free system
supports applications in disease modeling, genotoxic
compound screening, and mutational studies of hematopoiesis.
By enabling scalable production of B and NK cells it aims to
accelerate translational research for immunodeficiencies,
cancer immunotherapy, and hematopoietic disorders.},
keywords = {B lymphocytes (Other) / Cell differentiation (Other) / Cord
blood (Other) / Culture media (Other) / Killer cells (Other)
/ Mesenchymal stem cells (Other) / Natural (Other) /
Serum-free (Other)},
cin = {ED01},
ddc = {600},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41413562},
doi = {10.1038/s41598-025-30732-9},
url = {https://inrepo02.dkfz.de/record/307313},
}